Patents by Inventor Yoshihiro Ohue

Yoshihiro Ohue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Examination method for prediction of effect of treatment of cancer based on detection of cancer/testis antibodies
    Patent number: 11709165
    Abstract: [Object] To provide a novel examination method for a cancer treatment effect, screening method for a peptide for a cancer vaccine, and peptide and composition for inducing an immune response against cancer. [Solving Means] Provided are an examination method for a cancer treatment effect and a screening method for a peptide for a cancer vaccine each including detecting an antibody against a cancer/testis antigen or an anti-p53 antibody in a sample. It is suitable that an anti-XAGE1 antibody (IgG and/or IgA) be detected, or an anti-NY-ESO-1 antibody (IgG) be detected. Also provided are a novel peptide and novel composition for inducing immune responses against cancer.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: July 25, 2023
    Assignee: KAWASAKI GAKUEN EDUCATIONAL FOUNDATION
    Inventors: Mikio Oka, Eiichi Nakayama, Yoshihiro Ohue, Koji Kurose
  • METHOD FOR EXAMINING THERAPEUTIC EFFECT ON CANCER AND COMPOSITION FOR INDUCING IMMUNE RESPONSE
    Publication number: 20210148927
    Abstract: [Object] To provide a novel examination method for a cancer treatment effect, screening method fora peptide fora cancer vaccine, and peptide and composition for inducing an immune response against cancer. [Solving Means] Provided are an examination method for a cancer treatment effect and a screening method for a peptide for a cancer vaccine each including detecting an antibody against a cancer/testis antigen or an anti-p53 antibody in a sample. It is suitable that an anti-XAGE1 antibody (IgG and/or IgA) be detected, or an anti-NY-ESO-1 antibody (IgG) be detected. Also provided are a novel peptide and novel composition for inducing immune responses against cancer.
    Type: Application
    Filed: May 10, 2018
    Publication date: May 20, 2021
    Inventors: Mikio OKA, Eiichi NAKAYAMA, Yoshihiro OHUE, Koji KUROSE
  • PEPTIDE INDUCING XAGE-1B-SPECIFIC IMMUNE REACTION AND UTILIZATION OF SAME
    Publication number: 20120064102
    Abstract: The object of the present invention is to clarify functions of XAGE-1b and to develop a vaccine therapy for cancer based on XAGE-1b. Humoral immunity or cellular immunity is induced against XAGE-1b in lung cancer, by use of a peptide comprising an amino acid sequence of any one of (a) through (e) or by use of a peptide comprising an amino acid sequence of any one of (f) through (k).
    Type: Application
    Filed: May 21, 2010
    Publication date: March 15, 2012
    Applicant: NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
    Inventors: Eiichi Nakayama, Yoshihiro Ohue